Renovaro

Los Angeles, United States Founded: 2023 • Age: 3 yrs
Renovaro is focused on AI-driven cancer diagnostics and therapeutics.
Request Access

About Renovaro

Renovaro is a company based in Los Angeles (United States) founded in 2023. It operates as a AI-as-a-Service, and Professional Services. Renovaro has completed 1 acquisition, including Predictive Oncology. Renovaro offers products and services including AI Drug Discovery Platform, Precision Medicine Solutions, and Augusta Platform.

  • Headquarter Los Angeles, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Renovaro

Renovaro offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform, Precision Medicine Solutions, and Augusta Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI platform used for biomarker discovery in cancer.

Solutions tailored for personalized cancer treatment strategies.

Platform developed for neurological disease diagnosis support.

Funding Insights of Renovaro

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Renovaro

Renovaro has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Predictive Oncology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
AI-based platform for cancer diagnostics and precision medicine is utilized.
2002
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Renovaro

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Renovaro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Renovaro

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Renovaro

Frequently Asked Questions about Renovaro

When was Renovaro founded?

Renovaro was founded in 2023.

Where is Renovaro located?

Renovaro is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

What does Renovaro do?

Renovaro is engaged in leveraging AI technology for cancer diagnostics and precision medicine. The company operates in the healthcare and biotechnology sectors, offering solutions for biomarker discovery, early disease detection, and personalized treatments. Through its full-stack Bio-AI platform, Renovaro supports clinicians in improving patient outcomes across cancer and neurology care. Key initiatives include AI drug discovery, predictive analytics, and therapeutic development for specific genetic profiles. Strategic mergers and grants, such as with GEDiCube and BioSymetrics, enhance its capabilities in minimal residual disease detection and neurological diagnostics.

What products or services does Renovaro offer?

Renovaro offers AI Drug Discovery Platform, Precision Medicine Solutions, and Augusta Platform.

How many acquisitions has Renovaro made?

Renovaro has made 1 acquisition, including Predictive Oncology.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available